Patterns of Diabetes Screening and Prediabetes Treatment during Office Visits in the US

References

1. 1.↵
   American Diabetes Association. Classification and diagnosis of diabetes: Standards of Med Care in Diabetes—2018. Diabetes Care. 2018;41(Supplement 1):S13–S27.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Handelsman Y,
   2. Bloomgarden ZT,
   3. Grunberger G,
   4. et al

   . American Association of Clinical Endocrinologists and American College of Endocrinology–clinical practice guidelines for developing a diabetes mellitus comprehensive care plan-2015. Endocr Pract. 2015;21:413–37.

   OpenUrl
3. 3.↵
   1. Pippitt K,
   2. Li M,
   3. Gurgle H

   . Diabetes mellitus: screening and diagnosis. Am Fam Physician 2016;93:103–9.

   OpenUrl
4. 4.↵
   1. Siu AL

   , on behalf of the USPSTF. Screening for abnormal blood glucose and type 2 diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015;163:861–8.

   OpenUrlCrossRefPubMed
5. 5.↵
   Centers for Disease Control and Prevention. Diabetes Report Card 2014. Available from: https://www.cdc.gov/diabetes/pdfs/library/diabetesreportcard2014.pdf. Published 2015. Accessed December 3, 2018.
6. 6.↵
   Centers for Disease Control and Prevention. Diabetes Report Card 2017. Available from: https://www.cdc.gov/diabetes/pdfs/library/diabetesreportcard2017-508.pdf. Published 2018. Accessed December 3, 2018.
7. 7.↵
   Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017. Available from: https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf. Accessed December 3, 2018. Published 2017.
8. 8.↵
   1. Ligthart S,
   2. van Herpt T,
   3. Leening M,
   4. et al

   . Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study. Lancet Diabetes Endocrinol. 2016;4:44–51.

   OpenUrl
9. 9.↵
   1. Tabak A,
   2. Herder C,
   3. Rathmann W,
   4. Brunner E,
   5. Kivimaki M

   . Prediabetes: a high-risk state for diabetes development. Lancet. 2012;379:2279–90.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    American Diabetes Association. Economic costs of diabetes in the U.S. in 2017. Diabetes Care. 2018;41:917–28.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    American Medical Association and Centers for Disease Control and Prevention. Preventing type 2 diabetes: a guide to refer your patients with prediabetes to an evidence-based diabetes prevention program. Available from: https://preventdiabetesstat.org/toolkit.html. Accessed December 3, 2018.
12. 12.↵
    American Diabetes Association. Prevention or delay of type 2 diabetes: Standards of Med Care in Diabetes—2018. Diabetes Care. 2018;41(Suppl 1):S51–S4.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    National Center for Health Statistics. Ambulatory health care data. Atlanta, GA: Centers for Disease Control and Prevention [updated 2018 Nov 7; cited 2018 Nov 14]. Available from: https://www.cdc.gov/nchs/ahcd/index.htm. Accessed November 14, 2018.
14. 14.↵
    1. Goodman RA,
    2. Posner SF,
    3. Huang ES,
    4. Parekh AK,
    5. Koh HK

    . Defining and measuring chronic conditions: imperatives for research, policy, program, and practice. Prev Chronic Dis. 2013;10:E66.

    OpenUrlPubMed
15. 15.↵
    National Center for Health Statistics. 2015 NAMCS Micro-data file documentation. [updated 2017 Sep 11; cited 2018 Nov 14]; Available from: ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NAMCS/doc2015.pdf. Accessed November 15, 2018.
16. 16.↵
    1. Kiefer MM,
    2. Silverman JB,
    3. Young BA,
    4. Nelson KM

    . National patterns in diabetes screening: data from the National Health and Nutrition Examination Survey (NHANES) 2005–2012. J Gen Intern Med 2015;30:612–8.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Bullard KM,
    2. Ali MK,
    3. Imperatore G,
    4. et al

    . Receipt of glucose testing and performance of two US diabetes screening guidelines, 2007–2012. PLoS One. 2015;10:e0125249.

    OpenUrlPubMed
18. 18.↵
    1. Mehta S,
    2. Mocarski M,
    3. Wisniewski T,
    4. Gillespie K,
    5. Narayan KMV,
    6. Lang K

    . Primary care physicians' utilization of type 2 diabetes screening guidelines and referrals to behavioral interventions: a survey-linked retrospective study. BMJ Open Diabetes Res Care. 2017;5(1).e000406.

    OpenUrl
19. 19.↵
    American Hospital Association. Reminder: Medicare provides coverage of diabetes screening tests. Available from: https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNMattersArticles/downloads/SE0821.pdf. Published 2018. Accessed July 6, 2018.
20. 20.↵
    U.S. Preventive Services Task Force. Final research plan: abnormal blood glucose and type 2 diabetes mellitus: screening. 2018; Available from: https://www.uspreventiveservicestaskforce.org/Page/Document/final-research-plan/abnormal-blood-glucose-and-type-2-diabetes-mellitus-screening. Published 2018. Accessed December 3, 2018.
21. 21.↵
    1. Mainous AG,
    2. Tanner RJ,
    3. Baker R

    . Prediabetes diagnosis and treatment in primary care. J Am Board Fam Med 2016;29:283–5.

    OpenUrlAbstract/FREE Full Text
22. 22.↵
    Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374:1677–86.

    OpenUrlCrossRefPubMedWeb of Science
23. 23.↵
    Diabetes Prevention Program Research Group. The 10-Year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention. Diabetes Care. 2012;35:723–30.

    OpenUrlAbstract/FREE Full Text